PSM 212 Polio Poliomyelitis Epidemiology PAN AFP Acute Flaccid Paralysis Surveillance indicators

Both Type 2 and 3 are eradicated .. October 2019
0:01 Polio
0:35 Agent
2:00 Host
2:48 Clinical Spectrum - InApparent, Abortive Minor Illness, Non Paralytic, Paralytic asymmetrical , TRIPOD sign, descending paralysis
4:07 Treatment
4:10 New born
4:15 Reservoir Human to Human
4:25 Environment
4:50 Incidence Polio Vaccine started 1954 , PAN countries
5:18 India Polio Free from 2014 , last case 2011
5:43 Vaccine
6:55 Vaccine Derived Polio Virus VDPV cVDPV , iVDPV, aVDPV
7:57 Switch tOPV to bOPV 2015
8:15 EndGame Only IPV InActivated Polio Vaccine (no oral) 0.5ml intramuscular
8:50 FIPV - 2016 Fractional IntraDermal 0.1ml  two times , Difference between FIPV and IPV
9:50 Polio Surveillance
10:05 AFP Acute Flaccid Paralysis
10:58 Environmental Surveillance Sewage
11:12 Surveillance Indicators 1AFP per 1 lakh population, Adequate stool specimen, 2 stool specimens 24 hr apart within 14 day of onset of Paralysis , Documentation, WHO accredited Lab, 80% Follow up for Residual Paralysis 60 days after
13:54 Revision

#Polio #Poliomyelitis #epidemiology
switch endgame VDPV vaccine derived polio types mode of transmission incubation risk factors TRIPOD Sign Paralytic neck stiffness newborn baby reservoir world pakistan afganistan nigeria polio free india 2014 last case 2011 inactivated fractional IPV AFP acute flaccid paralysis surveillance sewage indicators Adequate stool Global Polio Laboratory Network (GPLN) WHO accredited lab feces feco-oral saliva country countries prevention steps taken stop eradicate eradication path